{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:28:28Z","timestamp":1791365308200,"version":"4.3.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES021800"],"award-info":[{"award-number":["R01ES021800"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES026057"],"award-info":[{"award-number":["R01ES026057"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32ES007148"],"award-info":[{"award-number":["T32ES007148"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["F31ES029794"],"award-info":[{"award-number":["F31ES029794"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12035-019-1565-7","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T10:03:54Z","timestamp":1554717834000},"page":"6986-7002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Increased MDR1 Transporter Expression in Human Brain Endothelial Cells Through Enhanced Histone Acetylation and Activation of Aryl Hydrocarbon Receptor Signaling"],"prefix":"10.1007","volume":"56","author":[{"given":"Dahea","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwik","family":"Gorczyca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayeshia","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-1037","authenticated-orcid":false,"given":"Lauren M.","family":"Aleksunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"1565_CR1","doi-asserted-by":"crossref","unstructured":"Abbott NJ (2014) Anatomy and physiology of the blood\u2013brain barriers. In: Hammarlund-Udenaes M, de Lange E, Thorne RG (eds) Drug delivery to the brain: physiological concepts, methodologies and approaches, vol 10. 1 edn. Springer-Verlag, New York, pp 731","DOI":"10.1007\/978-1-4614-9105-7_1"},{"issue":"1","key":"1565_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood\u2013brain barrier. Neurobiol Dis 37(1):13\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2009.07.030","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1565_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W Loscher","year":"2005","unstructured":"Loscher W, Potschka H (2005) Blood\u2013brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2(1):86\u201398. https:\/\/doi.org\/10.1602\/neurorx.2.1.86","journal-title":"NeuroRx"},{"issue":"2","key":"1565_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5732\/cjc.011.10320","volume":"31","author":"T Nakanishi","year":"2012","unstructured":"Nakanishi T, Ross DD (2012) Breast cancer resistance protein (BCRP\/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer 31(2):73\u201399. https:\/\/doi.org\/10.5732\/cjc.011.10320","journal-title":"Chin J Cancer"},{"issue":"2","key":"1565_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/tpj.2014.56","volume":"15","author":"S Sadhasivam","year":"2015","unstructured":"Sadhasivam S, Chidambaran V, Zhang X, Meller J, Esslinger H, Zhang K, Martin LJ, McAuliffe J (2015) Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. Pharmacogenomics J 15(2):119\u2013126. https:\/\/doi.org\/10.1038\/tpj.2014.56","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"1565_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/sj.bjp.0702804","volume":"128","author":"R Xie","year":"1999","unstructured":"Xie R, Hammarlund-Udenaes M, de Boer AG, de Lange EC (1999) The role of P-glycoprotein in blood\u2013brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (\u2212\/\u2212) and mdr1a (+\/+) mice. Br J Pharmacol 128(3):563\u2013568. https:\/\/doi.org\/10.1038\/sj.bjp.0702804","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1565_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1124\/mol.113.087197","volume":"84","author":"YY Chan","year":"2013","unstructured":"Chan YY, Kalpana S, Chang WC, Chang WC, Chen BK (2013) Expression of aryl hydrocarbon receptor nuclear translocator enhances cisplatin resistance by upregulating MDR1 expression in cancer cells. Mol Pharmacol 84(4):591\u2013602. https:\/\/doi.org\/10.1124\/mol.113.087197","journal-title":"Mol Pharmacol"},{"issue":"12","key":"1565_CR8","first-page":"607","volume":"1","author":"MM Cornwell","year":"1990","unstructured":"Cornwell MM (1990) The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription. Cell Growth Differ 1(12):607\u2013615","journal-title":"Cell Growth Differ"},{"issue":"1","key":"1565_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1074\/jbc.M004551200","volume":"276","author":"L Deng","year":"2001","unstructured":"Deng L, Lin-Lee YC, Claret FX, Kuo MT (2001) 2-Acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J Biol Chem 276(1):413\u2013420. https:\/\/doi.org\/10.1074\/jbc.M004551200","journal-title":"J Biol Chem"},{"issue":"18","key":"1565_CR10","doi-asserted-by":"publisher","first-page":"14581","DOI":"10.1074\/jbc.M010173200","volume":"276","author":"A Geick","year":"2001","unstructured":"Geick A, Eichelbaum M, Burk O (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276(18):14581\u201314587. https:\/\/doi.org\/10.1074\/jbc.M010173200","journal-title":"J Biol Chem"},{"issue":"8","key":"1565_CR11","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1016\/S0021-9258(18)53398-6","volume":"268","author":"ME Goldsmith","year":"1993","unstructured":"Goldsmith ME, Madden MJ, Morrow CS, Cowan KH (1993) A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J Biol Chem 268(8):5856\u20135860","journal-title":"J Biol Chem"},{"issue":"10","key":"1565_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048189","volume":"7","author":"R Gromnicova","year":"2012","unstructured":"Gromnicova R, Romero I, Male D (2012) Transcriptional control of the multi-drug transporter ABCB1 by transcription factor Sp3 in different human tissues. PLoS One 7(10):e48189. https:\/\/doi.org\/10.1371\/journal.pone.0048189","journal-title":"PLoS One"},{"issue":"7","key":"1565_CR13","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1128\/MCB.18.7.4377","volume":"18","author":"S Jin","year":"1998","unstructured":"Jin S, Scotto KW (1998) Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol Cell Biol 18(7):4377\u20134384","journal-title":"Mol Cell Biol"},{"issue":"11","key":"1565_CR14","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1016\/S0021-9258(18)53095-7","volume":"268","author":"MJ Madden","year":"1993","unstructured":"Madden MJ, Morrow CS, Nakagawa M, Goldsmith ME, Fairchild CR, Cowan KH (1993) Identification of 5\u2032 and 3\u2032 sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J Biol Chem 268(11):8290\u20138297","journal-title":"J Biol Chem"},{"issue":"10","key":"1565_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1349-7006.1991.tb01770.x","volume":"82","author":"M Ogura","year":"1991","unstructured":"Ogura M, Takatori T, Sugimoto Y, Tsuruo T (1991) Identification and characterization of three DNA-binding proteins on the promoter of the human MDR1 gene in drug-sensitive and -resistant cells. Jpn J Cancer Res 82(10):1151\u20131159","journal-title":"Jpn J Cancer Res"},{"issue":"47","key":"1565_CR16","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.1038\/sj.onc.1206950","volume":"22","author":"KW Scotto","year":"2003","unstructured":"Scotto KW (2003) Transcriptional regulation of ABC drug transporters. Oncogene 22(47):7496\u20137511. https:\/\/doi.org\/10.1038\/sj.onc.1206950","journal-title":"Oncogene"},{"issue":"2","key":"1565_CR17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0021-9258(19)75806-2","volume":"262","author":"K Ueda","year":"1987","unstructured":"Ueda K, Clark DP, Chen CJ, Roninson IB, Gottesman MM, Pastan I (1987) The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem 262(2):505\u2013508","journal-title":"J Biol Chem"},{"issue":"36","key":"1565_CR18","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1016\/S0021-9258(18)45397-5","volume":"262","author":"K Ueda","year":"1987","unstructured":"Ueda K, Pastan I, Gottesman MM (1987) Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J Biol Chem 262(36):17432\u201317436","journal-title":"J Biol Chem"},{"issue":"1","key":"1565_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1432-1033.1982.tb06847.x","volume":"127","author":"PD Cary","year":"1982","unstructured":"Cary PD, Crane-Robinson C, Bradbury EM, Dixon GH (1982) Effect of acetylation on the binding of N-terminal peptides of histone H4 to DNA. Eur J Biochem 127(1):137\u2013143","journal-title":"Eur J Biochem"},{"issue":"1","key":"1565_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0021-9258(18)54150-8","volume":"268","author":"L Hong","year":"1993","unstructured":"Hong L, Schroth GP, Matthews HR, Yau P, Bradbury EM (1993) Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 \"tail\" to DNA. J Biol Chem 268(1):305\u2013314","journal-title":"J Biol Chem"},{"issue":"3","key":"1565_CR21","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1073\/pnas.67.3.1616","volume":"67","author":"MT Sung","year":"1970","unstructured":"Sung MT, Dixon GH (1970) Modification of histones during spermiogenesis in trout: a molecular mechanism for altering histone binding to DNA. Proc Natl Acad Sci U S A 67(3):1616\u20131623","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1565_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0006-291X(69)90661-5","volume":"36","author":"A Inoue","year":"1969","unstructured":"Inoue A, Fujimoto D (1969) Enzymatic deacetylation of histone. Biochem Biophys Res Commun 36(1):146\u2013150","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1565_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0014-5793(93)81271-Z","volume":"317","author":"G Lopez-Rodas","year":"1993","unstructured":"Lopez-Rodas G, Brosch G, Georgieva EI, Sendra R, Franco L, Loidl P (1993) Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin. FEBS Lett 317(3):175\u2013180","journal-title":"FEBS Lett"},{"issue":"5","key":"1565_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.bcp.2007.04.007","volume":"74","author":"KB Glaser","year":"2007","unstructured":"Glaser KB (2007) HDAC inhibitors: clinical update and mechanism-based potential. Biochem Pharmacol 74(5):659\u2013671. https:\/\/doi.org\/10.1016\/j.bcp.2007.04.007","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1565_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","volume":"140","author":"IF Harrison","year":"2013","unstructured":"Harrison IF, Dexter DT (2013) Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Pharmacol Ther 140(1):34\u201352. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.05.010","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1565_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3892\/ol.2014.2714","volume":"9","author":"X Ni","year":"2015","unstructured":"Ni X, Li L, Pan G (2015) HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (review). Oncol Lett 9(2):515\u2013521. https:\/\/doi.org\/10.3892\/ol.2014.2714","journal-title":"Oncol Lett"},{"issue":"10","key":"1565_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","volume":"5","author":"M Dokmanovic","year":"2007","unstructured":"Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5(10):981\u2013989. https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-0324","journal-title":"Mol Cancer Res"},{"issue":"10","key":"1565_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2146\/ajhp090247","volume":"67","author":"SM Kavanaugh","year":"2010","unstructured":"Kavanaugh SM, White LA, Kolesar JM (2010) Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma. Am J Health Syst Pharm 67(10):793\u2013797. https:\/\/doi.org\/10.2146\/ajhp090247","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"1565_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bbrc.2015.09.182","volume":"467","author":"J Liu","year":"2015","unstructured":"Liu J, Li Y (2015) Trichostatin A and tamoxifen inhibit breast cancer cell growth by miR-204 and ERalpha reducing AKT\/mTOR pathway. Biochem Biophys Res Commun 467(2):242\u2013247. https:\/\/doi.org\/10.1016\/j.bbrc.2015.09.182","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1565_CR30","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.18632\/oncotarget.6802","volume":"7","author":"M Terranova-Barberio","year":"2016","unstructured":"Terranova-Barberio M, Roca MS, Zotti AI, Leone A, Bruzzese F, Vitagliano C, Scogliamiglio G, Russo D et al (2016) Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression. Oncotarget 7(7):7715\u20137731. https:\/\/doi.org\/10.18632\/oncotarget.6802","journal-title":"Oncotarget"},{"issue":"7","key":"1565_CR31","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1476-5381.2010.01188.x","volume":"162","author":"C Tiffon","year":"2011","unstructured":"Tiffon C, Adams J, van der Fits L, Wen S, Townsend P, Ganesan A, Hodges E, Vermeer M et al (2011) The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells. Br J Pharmacol 162(7):1590\u20131602. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01188.x","journal-title":"Br J Pharmacol"},{"key":"1565_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.placenta.2016.11.011","volume":"49","author":"H Duan","year":"2017","unstructured":"Duan H, Wang C, Zhou K, Wang T, Li Y, Qiu D, Li Q, Zhang Y et al (2017) The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines. Placenta 49:37\u201347. https:\/\/doi.org\/10.1016\/j.placenta.2016.11.011","journal-title":"Placenta"},{"issue":"4","key":"1565_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/sj.bjc.6603914","volume":"97","author":"V El-Khoury","year":"2007","unstructured":"El-Khoury V, Breuzard G, Fourre N, Dufer J (2007) The histone deacetylase inhibitor trichostatin a downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. Br J Cancer 97(4):562\u2013573. https:\/\/doi.org\/10.1038\/sj.bjc.6603914","journal-title":"Br J Cancer"},{"issue":"3","key":"1565_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yexcr.2011.11.010","volume":"318","author":"Y Xu","year":"2012","unstructured":"Xu Y, Jiang Z, Yin P, Li Q, Liu J (2012) Role for class I histone deacetylases in multidrug resistance. Exp Cell Res 318(3):177\u2013186. https:\/\/doi.org\/10.1016\/j.yexcr.2011.11.010","journal-title":"Exp Cell Res"},{"key":"1565_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.placenta.2017.08.077","volume":"58","author":"H Duan","year":"2017","unstructured":"Duan H, Zhou K, Zhang Y, Yue P, Wang T, Li Y, Qiu D, Wu J et al (2017) HDAC2 was involved in placental P-glycoprotein regulation both in vitro and vivo. Placenta 58:105\u2013114. https:\/\/doi.org\/10.1016\/j.placenta.2017.08.077","journal-title":"Placenta"},{"issue":"5","key":"1565_CR36","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","volume":"107","author":"B Poller","year":"2008","unstructured":"Poller B, Gutmann H, Krahenbuhl S, Weksler B, Romero I, Couraud PO, Tuffin G, Drewe J et al (2008) The human brain endothelial cell line hCMEC\/D3 as a human blood\u2013brain barrier model for drug transport studies. J Neurochem 107(5):1358\u20131368","journal-title":"J Neurochem"},{"issue":"1","key":"1565_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2045-8118-10-16","volume":"10","author":"B Weksler","year":"2013","unstructured":"Weksler B, Romero IA, Couraud PO (2013) The hCMEC\/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10(1):16. https:\/\/doi.org\/10.1186\/2045-8118-10-16","journal-title":"Fluids Barriers CNS"},{"issue":"13","key":"1565_CR38","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","volume":"19","author":"BB Weksler","year":"2005","unstructured":"Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A et al (2005) Blood\u2013brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19(13):1872\u20131874. https:\/\/doi.org\/10.1096\/fj.04-3458fje","journal-title":"FASEB J"},{"key":"1565_CR39","doi-asserted-by":"publisher","first-page":"Unit 23 26","DOI":"10.1002\/0471140856.tx2306s57","volume":"57","author":"KM Bircsak","year":"2013","unstructured":"Bircsak KM, Gibson CJ, Robey RW, Aleksunes LM (2013) Assessment of drug transporter function using fluorescent cell imaging. Curr Protoc Toxicol 57:Unit 23 26. https:\/\/doi.org\/10.1002\/0471140856.tx2306s57","journal-title":"Curr Protoc Toxicol"},{"issue":"12","key":"1565_CR40","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1200\/JCO.2008.19.0694","volume":"27","author":"E Galanis","year":"2009","unstructured":"Galanis E, Jaeckle KA, Maurer MJ, Reid JM, Ames MM, Hardwick JS, Reilly JF, Loboda A et al (2009) Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study. J Clin Oncol 27(12):2052\u20132058. https:\/\/doi.org\/10.1200\/JCO.2008.19.0694","journal-title":"J Clin Oncol"},{"issue":"2","key":"1565_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ijc.2910550221","volume":"55","author":"JS Coon","year":"1993","unstructured":"Frommel TO, Coon JS, Tsuruo T, Roninson IB (1993) Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines. Int J Cancer 55(2):297\u2013302","journal-title":"Int J Cancer"},{"issue":"2","key":"1565_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00280-010-1502-y","volume":"68","author":"BS Shin","year":"2011","unstructured":"Shin BS, Bulitta JB, Balthasar JP, Kim M, Choi Y, Yoo SD (2011) Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling. Cancer Chemother Pharmacol 68(2):465\u2013475. https:\/\/doi.org\/10.1007\/s00280-010-1502-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"1565_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1124\/mol.110.063685","volume":"78","author":"X Wang","year":"2010","unstructured":"Wang X, Sykes DB, Miller DS (2010) Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood\u2013brain barrier. Mol Pharmacol 78(3):376\u2013383. https:\/\/doi.org\/10.1124\/mol.110.063685","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1565_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1158\/1541-7786.MCR-07-0175","volume":"6","author":"O Polgar","year":"2008","unstructured":"To KK, Polgar O, Huff LM, Morisaki K, Bates SE (2008) Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol Cancer Res 6(1):151\u2013164. https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-0175","journal-title":"Mol Cancer Res"},{"issue":"17","key":"1565_CR45","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","volume":"23","author":"WK Kelly","year":"2005","unstructured":"Kelly WK, O'Connor OA, Krug LM, Chiao JH, Heaney M, Curley T, MacGregore-Cortelli B, Tong W et al (2005) Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. J Clin Oncol 23(17):3923\u20133931. https:\/\/doi.org\/10.1200\/JCO.2005.14.167","journal-title":"J Clin Oncol"},{"issue":"10","key":"1565_CR46","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.bbamem.2006.06.004","volume":"1758","author":"Y Wang","year":"2006","unstructured":"Wang Y, Hao D, Stein WD, Yang L (2006) A kinetic study of Rhodamine123 pumping by P-glycoprotein. Biochim Biophys Acta 1758(10):1671\u20131676. https:\/\/doi.org\/10.1016\/j.bbamem.2006.06.004","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"1565_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0167-4781(93)90280-Q","volume":"1172","author":"M van Groenigen","year":"1993","unstructured":"van Groenigen M, Valentijn LJ, Baas F (1993) Identification of a functional initiator sequence in the human MDR1 promoter. Biochim Biophys Acta 1172(1\u20132):138\u2013146","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1565_CR48","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.bcp.2008.11.001","volume":"77","author":"S Dauchy","year":"2009","unstructured":"Dauchy S, Miller F, Couraud PO, Weaver RJ, Weksler B, Romero IA, Scherrmann JM, De Waziers I et al (2009) Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC\/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol 77(5):897\u2013909. https:\/\/doi.org\/10.1016\/j.bcp.2008.11.001","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1565_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1124\/mol.66.3","volume":"66","author":"B Bauer","year":"2004","unstructured":"Bauer B, Hartz AM, Fricker G, Miller DS (2004) Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood\u2013brain barrier. Mol Pharmacol 66(3):413\u2013419. https:\/\/doi.org\/10.1124\/mol.66.3","journal-title":"Mol Pharmacol"},{"key":"1565_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2012.10.060","volume":"1491","author":"J Lemmen","year":"2013","unstructured":"Lemmen J, Tozakidis IE, Galla HJ (2013) Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood\u2013brain barrier. Brain Res 1491:1\u201313. https:\/\/doi.org\/10.1016\/j.brainres.2012.10.060","journal-title":"Brain Res"},{"issue":"25","key":"1565_CR51","doi-asserted-by":"publisher","first-page":"8585","DOI":"10.1523\/JNEUROSCI.2935-13.2014","volume":"34","author":"X Wang","year":"2014","unstructured":"Wang X, Campos CR, Peart JC, Smith LK, Boni JL, Cannon RE, Miller DS (2014) Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood\u2013brain and blood\u2013spinal cord barriers. J Neurosci 34(25):8585\u20138593. https:\/\/doi.org\/10.1523\/JNEUROSCI.2935-13.2014","journal-title":"J Neurosci"},{"issue":"2","key":"1565_CR52","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1096\/fj.10-169227","volume":"25","author":"X Wang","year":"2011","unstructured":"Wang X, Hawkins BT, Miller DS (2011) Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood\u2013brain barrier. FASEB J 25(2):644\u2013652. https:\/\/doi.org\/10.1096\/fj.10-169227","journal-title":"FASEB J"},{"issue":"5","key":"1565_CR53","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1541-7786.MCR-08-0296","volume":"7","author":"SN Kim","year":"2009","unstructured":"Kim SN, Kim NH, Lee W, Seo DW, Kim YK (2009) Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT\/enhancer binding protein beta and pCAF to the promoter region. Mol Cancer Res 7(5):735\u2013744. https:\/\/doi.org\/10.1158\/1541-7786.MCR-08-0296","journal-title":"Mol Cancer Res"},{"issue":"4","key":"1565_CR54","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1182\/blood-2004-10-4126","volume":"107","author":"Y Tabe","year":"2006","unstructured":"Tabe Y, Konopleva M, Contractor R, Munsell M, Schober WD, Jin L, Tsutsumi-Ishii Y, Nagaoka I et al (2006) Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells. Blood 107(4):1546\u20131554. https:\/\/doi.org\/10.1182\/blood-2004-10-4126","journal-title":"Blood"},{"issue":"1","key":"1565_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0014-5793(93)81601-U","volume":"336","author":"AL Clayton","year":"1993","unstructured":"Clayton AL, Hebbes TR, Thorne AW, Crane-Robinson C (1993) Histone acetylation and gene induction in human cells. FEBS Lett 336(1):23\u201326","journal-title":"FEBS Lett"},{"issue":"1","key":"1565_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0092-8674(93)90051-Q","volume":"72","author":"DY Lee","year":"1993","unstructured":"Lee DY, Hayes JJ, Pruss D, Wolffe AP (1993) A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72(1):73\u201384","journal-title":"Cell"},{"issue":"Pt 1","key":"1565_CR57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/jcs.99.1.13","volume":"99","author":"BM Turner","year":"1991","unstructured":"Turner BM (1991) Histone acetylation and control of gene expression. J Cell Sci 99(Pt 1):13\u201320","journal-title":"J Cell Sci"},{"issue":"5260","key":"1565_CR58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.272.5260.371","volume":"272","author":"AP Wolffe","year":"1996","unstructured":"Wolffe AP (1996) Histone deacetylase: a regulator of transcription. Science 272(5260):371\u2013372","journal-title":"Science"},{"issue":"6","key":"1565_CR59","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1124\/mol.51.6.963","volume":"51","author":"R Sundseth","year":"1997","unstructured":"Sundseth R, MacDonald G, Ting J, King AC (1997) DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter. Mol Pharmacol 51(6):963\u2013971","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1565_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jneumeth.2011.05.012","volume":"199","author":"K Hatherell","year":"2011","unstructured":"Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ (2011) Development of a three-dimensional, all-human in vitro model of the blood\u2013brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 199(2):223\u2013229. https:\/\/doi.org\/10.1016\/j.jneumeth.2011.05.012","journal-title":"J Neurosci Methods"},{"issue":"12","key":"1565_CR61","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/jphp.12803","volume":"69","author":"C Kulczar","year":"2017","unstructured":"Kulczar C, Lubin KE, Lefebvre S, Miller DW, Knipp GT (2017) Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood\u2013brain barrier coculture model. J Pharm Pharmacol 69(12):1684\u20131696. https:\/\/doi.org\/10.1111\/jphp.12803","journal-title":"J Pharm Pharmacol"},{"key":"1565_CR62","doi-asserted-by":"publisher","unstructured":"You D, Shin HM, Mosaad F, Richardson J, Aleksunes L (2019) Brain-region specific regulation of histone acetylation and efflux transporters in mice. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.22318","DOI":"10.1002\/jbt.22318"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1565-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:36:31Z","timestamp":1663245391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1565-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1565-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}